Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO 2019 Congress

How to handle comorbidities in the treatment decision of stages I to III NSCLC

Pulmonary risk assessment

Date

30 Sep 2019

Session

How to handle comorbidities in the treatment decision of stages I to III NSCLC

Topics

Tumour Site

Non-Small Cell Lung Cancer

Presenters

Paul Baas

Authors

P. Baas

Author affiliations

  • Thoracic Oncology, The Netherlands Cancer Institute Antoni van Leeuwenhoek Hospital, 1066 CX - Amsterdam/NL

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Login

Resources from the same session

Cardiac risk assessment

Presenter: Alessandro Brunelli

Session: How to handle comorbidities in the treatment decision of stages I to III NSCLC

Resources:

Slides

Webcast

Other significant comorbidities

Presenter: Thierry Berghmans

Session: How to handle comorbidities in the treatment decision of stages I to III NSCLC

Resources:

Slides

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.